# Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

> **NCT01878799** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis C
- HIV

## Interventions

- **DRUG:** GS-7977/GS- 5885 FDC

## Key facts

- **NCT ID:** NCT01878799
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878799, "Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01878799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*